C5 Acquisition Inkomsten in het verleden
Verleden criteriumcontroles 2/6
There is insufficient data on C5 Acquisition's performance over the last few years.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
| Capital Markets Groei van de industrie | 10.3% |
| Inkomstengroei | n/a |
| Rendement op eigen vermogen | n/a |
| Nettomarge | n/a |
| Laatste winstupdate | 31 Mar 2023 |
Recente prestatie-updates uit het verleden
Geen updates
Recent updates
Opbrengsten en kosten
Hoe C5 Acquisition geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Mar 23 | 0 | 4 | 2 | 0 |
| 31 Dec 22 | 0 | 2 | 2 | 0 |
| 30 Sep 22 | 0 | -2 | 1 | 0 |
Kwaliteitswinsten: CXAC has high quality earnings.
Groeiende winstmarge: CXAC became profitable in the past.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: Unable to establish if CXAC's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Versnelling van de groei: Unable to compare CXAC's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years.
Winst versus industrie: CXAC has become profitable in the last year, making it difficult to compare its past year earnings growth to the Capital Markets industry (2.4%).
Rendement op eigen vermogen
Hoge ROE: CXAC's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.